About this episode

Kurt Jacobus discusses the importance of early revenue as proof in medtech and shares insights on regulatory strategies and investor relations.

In this episode of Medsider Radio, we sat down with Kurt Jacobus , co-founder and CEO of restor3d . restor3d provides patient-specific orthopedic implants using 3D printing and advanced software. Kurt has over two decades of experience in medtech entrepreneurship, including successful exits to Enovis and NuVasive. Prior to his career in medical devices, Kurt was a consultant at McKinsey & Company. He holds a PhD in Mechanical Engineering and is an Adjunct Professor at Georgia Tech. In this interview, Kurt discusses how restor3d used the FDA's 520(b) pathway to generate revenue and regulatory proof simultaneously, why self-regulating beyond FDA requirements makes submissions a competitive barrier, and how to approach investor relationships and board construction with long-term thinking. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. And if you’re ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising…

People in this episode

Host: Scott Nelson

Guest: Kurt Jacobus

Topics covered

• medtech
• entrepreneurship
• 3D printing
• regulatory strategy
• investor relations

Keywords

• medtech
• restor3d
• Kurt Jacobus
• FDA
• 3D printing
• orthopedic implants
• entrepreneurship
• investor relations

Mentioned in this episode

Organizations: restor3d, Enovis, NuVasive, McKinsey & Company

Places: Georgia Tech

More episodes of Medsider: Learn from Medtech and Healthtech Founders and CEOs

• Building Clinical Evidence Around Your Target Market: Interview with Teal Health CEO Kara Egan · June 8, 2026 · 56 min
• Solving for Healthcare’s Broken Doorway: Interview with OnMed CEO Karthik Ganesh · June 1, 2026 · 51 min
• Meeting Patients Where They Are: Interview with Clairity CEO Dr. Connie Lehman · May 25, 2026 · 50 min
• Translating Academic IP into a Medtech Startup: Interview with Echopoint Medical CEO Antony Odell · May 18, 2026 · 52 min

Explore listener stats, chart rankings, contacts and more on the Medsider: Learn from Medtech and Healthtech Founders and CEOs podcast page.